Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Jun-Yi Wu, Zhong-Xia Wang, Guang Zhang, Xian Lu, Guang-Hui Qiang, Wei Hu, An-Lai Ji, Jun-Hua Wu & Chun-Ping Jiang. (2018) Targeted co-delivery of Beclin 1 siRNA and FTY720 to hepatocellular carcinoma by calcium phosphate nanoparticles for enhanced anticancer efficacy. International Journal of Nanomedicine 13, pages 1265-1280.
Read now
Read now
Samaneh Mohammadi, Parvin Zakeri-Milani, Nasim Golkar, Samad Mussa Farkhani, Ali Shirani, Javid Shahbazi Mojarrad, Ali Nokhodchi & Hadi Valizadeh. (2018) Synthesis and cellular characterization of various nano-assemblies of cell penetrating peptide-epirubicin-polyglutamate conjugates for the enhancement of antitumor activity. Artificial Cells, Nanomedicine, and Biotechnology 46:8, pages 1572-1585.
Read now
Read now
Jialing Dai, Shangcong Han, Fang Ju, Mei Han, Lisa Xu, Ruoyu Zhang & Yong Sun. (2018) Preparation and evaluation of tumour microenvironment response multistage nanoparticles for epirubicin delivery and deep tumour penetration. Artificial Cells, Nanomedicine, and Biotechnology 46:sup2, pages 860-873.
Read now
Read now
Roghayeh Rastegar, Hamid Akbari Javar, Mehdi Khoobi, Poua Dehghan Kelishadi, Gholam Hossein Yousefi, Mahmoud Doosti, Mohammad Hossien Ghahremani, Ahmad Shariftabrizi, Fatemeh Imanparast, Elham Gholibeglu & Mahdi Gholami. (2018) Evaluation of a novel biocompatible magnetic nanomedicine based on beta-cyclodextrin, loaded doxorubicin-curcumin for overcoming chemoresistance in breast cancer. Artificial Cells, Nanomedicine, and Biotechnology 46:sup2, pages 207-216.
Read now
Read now
Sai Kiran S. S. Pindiprolu, Praveen T. Krishnamurthy, Pavan Kumar Chintamaneni & Veera Venkata Satyanarayana Reddy Karri. (2018) Nanocarrier based approaches for targeting breast cancer stem cells. Artificial Cells, Nanomedicine, and Biotechnology 46:5, pages 885-898.
Read now
Read now
Articles from other publishers (17)
Mohsen Safaei, Fatemeh Khalighi, Fatemeh Akhavan Behabadi, Zahra Abpeikar, Arash Goodarzi, Seyed Amin Kouhpayeh, Sohrab Najafipour & Vahid Ramezani. (2023) Liposomal nanocarriers containing siRNA as small molecule-based drugs to overcome cancer drug resistance. Nanomedicine.
Crossref
Crossref
Albert Sufianov, Aferin Beilerli, Valentin Kudriashov, Tatiana Ilyasova, Bu Wenjie & Ozal Beylerli. (2023) Advances in transdermal siRNAs delivery: A review of current research progress. Non-coding RNA Research 8:3, pages 392-400.
Crossref
Crossref
Mehrab Pourmadadi, Shima Ostovar, Gustavo Ruiz-Pulido, Dilawar Hassan, Maryam Souri, Amanda-Lee Ezra Manicum, Razieh Behzadmehr, Sonia Fathi-karkan, Abbas Rahdar, Dora I. Medina & Sadanand Pandey. (2023) Novel epirubicin-loaded nanoformulations: Advancements in polymeric nanocarriers for efficient targeted cellular and subcellular anticancer drug delivery. Inorganic Chemistry Communications 155, pages 110999.
Crossref
Crossref
Jiayu Zhang, Xiaomeng Cai, Rui Dou, Chen Guo, Jiaruo Tang, Yi Hu, Hanqing Chen & Jun Chen. (2023) Poly(β-amino ester)s-based nanovehicles: Structural regulation and gene delivery. Molecular Therapy - Nucleic Acids 32, pages 568-581.
Crossref
Crossref
Yichuan Jiang, Yueyao Jiang, Min Li & Qian Yu. (2023) Will nanomedicine become a good solution for the cardiotoxicity of chemotherapy drugs?. Frontiers in Pharmacology 14.
Crossref
Crossref
Md Abdus Subhan. 2023.
Muhammad Muzamil Khan & Vladimir P. Torchilin. (2022) Recent Trends in Nanomedicine-Based Strategies to Overcome Multidrug Resistance in Tumors. Cancers 14:17, pages 4123.
Crossref
Crossref
Maha Ali Alghamdi, Antonino N. Fallica, Nicola Virzì, Prashant Kesharwani, Valeria Pittalà & Khaled Greish. (2022) The Promise of Nanotechnology in Personalized Medicine. Journal of Personalized Medicine 12:5, pages 673.
Crossref
Crossref
Manoja K. Brahma, Eduardo H. Gilglioni, Lang Zhou, Eric Trépo, Pengyu Chen & Esteban N. Gurzov. (2021) Oxidative stress in obesity-associated hepatocellular carcinoma: sources, signaling and therapeutic challenges. Oncogene 40:33, pages 5155-5167.
Crossref
Crossref
Cristian Vergallo, Muhammad Nadeem Hafeez, Dalila Iannotta, Hélder A. Santos, Nicola D’Avanzo, Luciana Dini, Felisa Cilurzo, Massimo Fresta, Luisa Di Marzio & Celia Christian. 2021. Bio-Nanomedicine for Cancer Therapy. Bio-Nanomedicine for Cancer Therapy
3
27
.
Dima Hattab & Athirah Bakhtiar. (2020) Bioengineered siRNA-Based Nanoplatforms Targeting Molecular Signaling Pathways for the Treatment of Triple Negative Breast Cancer: Preclinical and Clinical Advancements. Pharmaceutics 12:10, pages 929.
Crossref
Crossref
Deepti Parashar, Vinoth Rajendran, Ravi Shukla & Ramakrishna Sistla. (2020) Lipid-based nanocarriers for delivery of small interfering RNA for therapeutic use. European Journal of Pharmaceutical Sciences 142, pages 105159.
Crossref
Crossref
Chen Du, Yan Liang, Qingming Ma, Qianwen Sun, Jinghui Qi, Jie Cao, Shangcong Han, Mingtao Liang, Bo Song & Yong Sun. (2019) Intracellular tracking of drug release from pH-sensitive polymeric nanoparticles via FRET for synergistic chemo-photodynamic therapy. Journal of Nanobiotechnology 17:1.
Crossref
Crossref
Jianguo Gao, Lingxiao Chen, Ruogu Qi, Zhihua Zhou, Zaian Deng, Jue Shi, Tao Qin, Shengzhe Zhao, Yuna Qian & Jianliang Shen. (2019) Simultaneous delivery of gene and chemotherapeutics via copolymeric micellar nanoparticles to overcome multiple drug resistance to promote synergistic tumor suppression. Journal of Biomaterials Applications 34:1, pages 130-140.
Crossref
Crossref
Xinjian Qu, Yang Hu, Huifeng Wang, Haiqing Song, Megan Young, Fujian Xu, Ying Liu & Gang Cheng. (2019) Biomimetic Dextran–Peptide Vectors for Efficient and Safe siRNA Delivery. ACS Applied Bio Materials 2:4, pages 1456-1463.
Crossref
Crossref
Ivan V. ChernikovDaniil V. GladkikhMariya I. MeschaninovaUlyana A. KarelinaAlya G. Ven'yaminovaMarina A. ZenkovaValentin V. VlassovElena L. Chernolovskaya. (2019)
Fluorophore Labeling Affects the Cellular Accumulation and Gene Silencing Activity of Cholesterol-Modified siRNAs
In Vitro
. Nucleic Acid Therapeutics 29:1, pages 33-43.
Crossref
Crossref
Hongdan Li, Cheng Yang, Yijie Shi & Liang Zhao. (2018) Exosomes derived from siRNA against GRP78 modified bone-marrow-derived mesenchymal stem cells suppress Sorafenib resistance in hepatocellular carcinoma. Journal of Nanobiotechnology 16:1.
Crossref
Crossref